| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/29/2010 | CN101843775A Chinese medicament for treating diabetic nephropathy |
| 09/29/2010 | CN101843774A Chinese medicament for treating diabetic eyeground pathological changes |
| 09/29/2010 | CN101843772A Chinese medicament for treating diabetic oculopathy |
| 09/29/2010 | CN101843770A Chinese medicament for treating diabetic oculopathy |
| 09/29/2010 | CN101843763A Traditional Chinese medicine capable of treating complicated symptom of diabetes and stagnant heat and application thereof |
| 09/29/2010 | CN101843755A Chinese medicament for treating diabetic cardiopathy |
| 09/29/2010 | CN101843752A Chinese medicament for treating diabetic eyeground pathological changes |
| 09/29/2010 | CN101843751A Chinese medicament for treating diabetic nephropathy |
| 09/29/2010 | CN101843743A Chinese medicament for treating diabetic nephropathy |
| 09/29/2010 | CN101843738A Chinese medicament for treating diabetic feet |
| 09/29/2010 | CN101843737A Chinese medicament for treating diabetic feet |
| 09/29/2010 | CN101843728A Chinese medicament for treating diabetic oculopathy |
| 09/29/2010 | CN101843727A Chinese medicament for treating diabetic oculopathy |
| 09/29/2010 | CN101843725A Chinese medicament for treating diabetic oculopathy |
| 09/29/2010 | CN101843715A Chinese medicament for treating diabetic feet |
| 09/29/2010 | CN101843696A Chinese medicament for treating diabetic nephropathy |
| 09/29/2010 | CN101843693A Chinese medicament for treating diabetic nephropathy |
| 09/29/2010 | CN101843681A Application of composite containing polygonum orientale in preparing medicaments for preventing and treating diabetes and complication thereof |
| 09/29/2010 | CN101843665A Fig leaf extract lozenges |
| 09/29/2010 | CN101843651A Method for preparing folium cortex eucommiae extract microcapsules |
| 09/29/2010 | CN101843632A Application of miR-145 in preparing medicament for treating inflammation |
| 09/29/2010 | CN101843623A External fat-increasing preparation and application thereof |
| 09/29/2010 | CN101843617A Slow release preparation of compound Repaglinide-metformin hydrochloride |
| 09/29/2010 | CN101843613A Vitamin EC chewable tablets with high stability and preparation method thereof |
| 09/29/2010 | CN101843587A Method for preparing ornithine aspartate powder injection for injection |
| 09/29/2010 | CN101843581A Multi-portion intra-oral dosage form with organoleptic properties |
| 09/29/2010 | CN101843308A Propolis soft capsule and preparation method thereof |
| 09/29/2010 | CN101524190B Disease preventing and curing medicinal mouth-muffle and medicinal composition |
| 09/29/2010 | CN101518516B Sodium riboflavin phosphate lyophilized powder for injection and preparation method thereof |
| 09/29/2010 | CN101507727B Traditional Chinese medicine composition capable of reducing blood fat and preparation method thereof |
| 09/29/2010 | CN101352429B Use of tiopronin in preparing medicament for treating liver function damage induced by cerebral ischemia, diabetes and obesity |
| 09/29/2010 | CN101314591B Novel pyrazoles highly-selective marijuana acceptor-1antagon and/or reversed activation agent |
| 09/29/2010 | CN101301293B Acidum folicum effervescent tablet and preparation thereof |
| 09/29/2010 | CN101297917B Chinese medicinal composition for treating hyperlipemia and preparation thereof |
| 09/29/2010 | CN101264226B Quality detecting method of diabetes treating medicine |
| 09/29/2010 | CN101249131B Gynostemma pentaphylla effective ingredient extract |
| 09/29/2010 | CN101244060B Leonurus heterophyllus alkaloid composition |
| 09/29/2010 | CN101209256B Polydatin medicinal composition containing polyvinyl pyrrolidone |
| 09/29/2010 | CN101189988B Method for concentrating coix seed oil capable of reducing blood fat and low density cholesterol |
| 09/29/2010 | CN101129469B Traditional Chinese medicine composition for preventing and controlling cardiovascular disease |
| 09/29/2010 | CN101116504B Health products for reducing blood fat and method for preparing the same |
| 09/29/2010 | CN101035762B Alkil-pyridines as 11-beta inhibitors for diabetes |
| 09/29/2010 | CN101035548B Steroidal saponin pharmaceutical composition, the preparation method and use thereof |
| 09/29/2010 | CN101032511B Health wine for conditioning blood sugar and the preparing method |
| 09/28/2010 | USRE41783 Pyrrolo[2,3-D]pyrimidine compounds |
| 09/28/2010 | US7803840 Use of certain dialkyl fumarates for the preparation of pharmaceutical preparations for use in transplantation medicine or for the therapy of autoimmune diseases and said compositions in the form of micro-tablets or pellets; dimethyl fumarate |
| 09/28/2010 | US7803819 dipeptidyl peptidase IV (DPP-IV) inhibitors, such as 2S)-1-{[(1S)-2-(5-cyano-2-methyl-indol-1-yl)-1-methyl-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile, useful for the treatment and/or prophylaxis non-insulin dependent diabetes and impaired glucose tolerance; antidiabetic agents |
| 09/28/2010 | US7803811 1-methoxy-2-methyl-3-[(4-nitrophenyl)sulphonyl]indolizine, used as angiogenesis inhibitors |
| 09/28/2010 | US7803807 such as trans-2-[3'-oxospiro [cyclohexane- 1,1'(3'H)-isobenzofuran]-4yl]-5-(2-pyridyl) imidazo[4,5-b]pyridine, exhibiting neuropeptide Y antagonistic effects, used for the treatment of cardiovascular, nervous system, metabolic, gastrointestinal, sexual and respiratory system disorders; pharmacokinetics |
| 09/28/2010 | US7803805 3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl)-3-oxo-propionitrile mono citrate salt; immunosuppressants, autoimmune diseases, skin disorders, Crohn's disease, antidiabetic agents, anticancer agents, antiarthritic agents |
| 09/28/2010 | US7803795 and nitric oxide synthase inhibitor; e.g. 1-(phenylmethyl)-4-piperidyl-6-phthalazine-3one; antiinflammatory agent; preserve the cellular energy level: survival of ischaemic tissues after insult; neurodegenerative diseases: stroke, Alzheimer's and Parkinson's diseases, atherosclerosis, osteoarthritis |
| 09/28/2010 | US7803766 administering gastrin/(cholecystokinin (CCK) receptor ligand and a factor for complementing gastrin for islet neogenesis therapy; sustained release; for expanding a functional beta cell mass of pancreatic islet transplants; reduces amount of stem cells necessary for treatment; long-acting action |
| 09/28/2010 | US7803749 Prevent signal transduction passageways; kinase inhibitor; modulate immunology response |
| 09/28/2010 | US7803562 Method for screening human intestinal Npt2B modulatory agents |
| 09/28/2010 | CA2574875C Aryl-pyridine derivatives as 11-beta hsd1 inhibitors |
| 09/28/2010 | CA2553160C 2-heteroaryl-substituted benzimidazole derivative |
| 09/28/2010 | CA2536929C 2-substituted benzimidazole piperidines analogs as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 09/28/2010 | CA2449485C Pharmaceutical and/or cosmetic compositions for the treatment of localised adiposities and cellulite |
| 09/28/2010 | CA2430366C Improved oral delivery of peptides using enzyme-cleavable membrane translocators |
| 09/28/2010 | CA2429267C Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same |
| 09/28/2010 | CA2395772C Sulfonamide-containing heterocyclic compounds |
| 09/28/2010 | CA2386417C Phenyl- and pyridyl-tetrahydropyridines having tnf-inhibiting activity |
| 09/28/2010 | CA2383524C Thiazolyl alkynyl compounds and methods of use thereof |
| 09/28/2010 | CA2285746C Osteoprotegerin binding proteins and receptors |
| 09/23/2010 | WO2010108155A1 Modulators of cystic fibrosis transmembrane conductance regulator |
| 09/23/2010 | WO2010108114A2 Polyunsaturated fatty acid synthase nucleic acid molecules and polypeptides, compositions, and methods of making and uses thereof |
| 09/23/2010 | WO2010107866A2 Catecholamine derivatives for obesity and neurological disorders |
| 09/23/2010 | WO2010107809A2 Methods for preparing dpp-iv inhibitor compounds |
| 09/23/2010 | WO2010107768A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase |
| 09/23/2010 | WO2010107765A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase |
| 09/23/2010 | WO2010107704A2 Ellipticine compounds for treating obesity |
| 09/23/2010 | WO2010107177A2 Composition for prevention or treatment of obesity, dyslipidemia, fatty liver or insulin resistance syndrome comprising camphene as active ingredients |
| 09/23/2010 | WO2010107170A1 Composition for treating metabolic diseases |
| 09/23/2010 | WO2010107040A1 Solid preparation containing npy y5 receptor antagonist |
| 09/23/2010 | WO2010106798A1 Agent for promoting energy consumption |
| 09/23/2010 | WO2010106187A2 Inhibitors of cathepsin s for prevention or treatment of obesity-associated disorders |
| 09/23/2010 | WO2010106083A1 Combination therapies for treating metabolic disorders |
| 09/23/2010 | WO2010106082A1 Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders |
| 09/23/2010 | WO2010106081A1 Piperidine derivatives as nk3 receptor antagonists |
| 09/23/2010 | WO2010106076A1 Ppar metabolic stimulator based on unsaturated free fatty acid esters, oily composition and food additive containing same |
| 09/23/2010 | WO2010073011A3 Heterocyclic compounds and their use as ampk activators |
| 09/23/2010 | WO2010065069A3 Compositions comprising renin-angiotensin aldosterone system inhibitors and lipoic acid compounds, and the use thereof for the treatment of renin-angiotensin aldosterone system related disorders |
| 09/23/2010 | WO2010062863A3 Compositions containing satiogens and methods of use |
| 09/23/2010 | WO2010062824A3 Enhanced bioactive formulations of resveratrol |
| 09/23/2010 | WO2010059639A3 Hydroxyadamantyl inhibitors of dipeptidylpeptidase iv |
| 09/23/2010 | WO2009110983A8 Retinaldehyde in the treatment of obesity, diabetes and other conditions |
| 09/23/2010 | US20100240866 Modified gherlin peptides |
| 09/23/2010 | US20100240766 Agent for Improving Carcass Performance in Finishing Hogs |
| 09/23/2010 | US20100240751 Methods |
| 09/23/2010 | US20100240743 Cannabinoid receptor modulator |
| 09/23/2010 | US20100240734 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 09/23/2010 | US20100240731 Lipopeptides for delivery of nucleic acids |
| 09/23/2010 | US20100240726 Compositions for treating amyloid associated diseases |
| 09/23/2010 | US20100240724 Edible Film |
| 09/23/2010 | US20100240717 Novel thiophene derivatives as s1p1/edg1 receptor agonists |
| 09/23/2010 | US20100240711 Solid preparation comprising npyy5 receptor antagonist |
| 09/23/2010 | US20100240687 Method for checking and controlling the mammalian lactic acid fermentation process/aerobic glucose fermentation metabolic pathway in mammalian organism |
| 09/23/2010 | US20100240683 Combination therapy, composition and methods for the treatment of cardiovascular disorders |
| 09/23/2010 | US20100240679 4-Phenylpiperidine Derivatives as Renin Inhibitors |
| 09/23/2010 | US20100240677 Compounds as PDE IV and TNF Inhibitors |